K. Yuen

发表

Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes

W. Kenneth Ward, Joseph El Youssef, Jessica R. Castle, 2010, Diabetes Care.

Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic

K. Yuen, J. Findling, L. Blevins, 2020, Endocrine Practice.

Alterations of the GH/IGF-I axis and gut microbiome after traumatic brain injury: a new clinical syndrome?

B. Masel, M. Sheffield-Moore, R. Urban, 2020, The Journal of clinical endocrinology and metabolism.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.

S. Radovick, A. Hoffman, K. Yuen, 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Glucagon Stimulation Testing in Adult Growth Hormone Deficiency A 2014 Update

K. Yuen, 2014 .

Glucagon Stimulation Testing in Assessing for Adult Growth Hormone Deficiency: Current Status and Future Perspectives

K. Yuen, 2011, ISRN endocrinology.

Glucagon testing in adult growth hormone deficiency-current status and future perspectives

K. Yuen, 2010 .

Growth hormone dosing variables in growth hormone-deficient adults.

K. Yuen, D. Cook, 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

The metabolic effects of short‐term administration of physiological versus high doses of GH therapy in GH deficient adults

P. Gluckman, D. Dunger, K. Ong, 2002, Clinical endocrinology.

Insulin-Like Growth Factor I and Impaired Glucose Tolerance

D. Dunger, K. Ong, K. Yuen, 2005, Hormone Research in Paediatrics.

Acromegaly: clinical description and diagnosis

K. Yuen, A. Beckers, 2021, Gigantism and Acromegaly.

MEDICAL THERAPY FOR ACROMEGALY: TOWARDS THE PRACTICE OF A PERSONALIZED MEDICINE APPROACH.

K. Yuen, 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Testosterone and cardiovascular disease: controversy or wake-up call?

K. Yuen, 2014 .

Primary treatment regimen and diabetes insipidus as predictors of health outcomes in adults with childhood-onset craniopharyngioma.

M. Kołtowska-Häggström, M. Geffner, K. Yuen, 2014, The Journal of clinical endocrinology and metabolism.

Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs

A. Hoffman, C. Boguszewski, K. Yuen, 2021, Frontiers in Endocrinology.

The current state of long-acting growth hormone preparations for growth hormone therapy

K. Yuen, B. Biller, B. Miller, 2018, Current opinion in endocrinology, diabetes, and obesity.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, The Lancet.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults.

D. Dunger, J. Frystyk, M. Umpleby, 2004, The Journal of clinical endocrinology and metabolism.

Therapeutic aspects of growth hormone and insulin‐like growth factor‐I treatment on visceral fat and insulin sensitivity in adults

D. Dunger, K. Yuen, 2007, Diabetes, obesity & metabolism.

Insulin Resistance Is an Intrinsic Defect Independent of Fat Mass in Women with Turner’s Syndrome

D. Dunger, P. Murgatroyd, K. Yuen, 2006, Hormone Research in Paediatrics.

Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes

M. Riddle, T. D. de Bruin, K. Yuen, 2015, Diabetes, obesity & metabolism.

The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults.

P. Gluckman, D. Dunger, K. Ong, 2002, The Journal of clinical endocrinology and metabolism.

Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone

K. Yuen, D. Nguyen, A. Moraitis, 2017, Journal of the Endocrine Society.

ASSOCIATION BETWEEN MIFEPRISTONE DOSE, EFFICACY, AND TOLERABILITY IN PATIENTS WITH CUSHING SYNDROME.

Gavin Williams, K. Yuen, H. Kushner, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

AACE/ACE Disease State Clinical Review: Medical Management of Cushing Disease.

A. Hoffman, K. Yuen, A. Hamrahian, 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

An Update on Immune Checkpoint Inhibitor-related Hypophysitis

A. Azadi, K. Yuen, E. Fonkem, 2020 .

Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database

A. Hoffman, M. Fleseriu, D. Clemmons, 2022, International journal of endocrinology.

Endocrine Complications in Childhood Cancer Survivors

K. Yuen, 2015 .

Cost-effectiveness and efficacy of a novel combination regimen in acromegaly: a prospective, randomized trial.

S. Melmed, K. Yuen, T. Araki, 2020, The Journal of clinical endocrinology and metabolism.

Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice

C. Boguszewski, G. Johannsson, K. Yuen, 2021, Pituitary.

Growth hormone replacement in patients with a history of malignancy: a review of the literature and best practice for offering treatment

K. Yuen, V. Popović, 2015, Expert review of endocrinology & metabolism.

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.

M. Vance, K. Yuen, D. Cook, 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency.

W. Rooney, C. Roberts, J. Frystyk, 2014, The Journal of clinical endocrinology and metabolism.

Growth Hormone Effects on Glucose Metabolism

D. Dunger, K. Yuen, B. Salgin, 2007, Hormone Research in Paediatrics.

Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low‐dose GH therapy in adults with severe GH deficiency

D. Dunger, K. Yuen, 2006, Clinical endocrinology.

Effects of Growth Hormone on Visceral Fat and Insulin Sensitivity

K. Yuen, D. Cook, 2006 .

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

G. Brabant, L. Cohen, S. Radovick, 2022, European journal of endocrinology.

Macimorelin as a Diagnostic Test for Adult GH Deficiency

P. Chanson, A. Zakrzewska, M. Korbonits, 2018, The Journal of clinical endocrinology and metabolism.

Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency

M. Bidlingmaier, J. Frystyk, K. Yuen, 2015, Pituitary.

Individual IGF-I Responsiveness to a Fixed Regimen of Low-Dose Growth Hormone Replacement Is Increased with Less Variability in Obese Compared to Non-Obese Adults with Severe Growth Hormone Deficiency

D. Dunger, K. Yuen, D. Cook, 2006, Hormone Research in Paediatrics.

Macimorelin (AEZS-130)-Stimulated Growth Hormone (GH) Test: Validation of a Novel Oral Stimulation Test for the Diagnosis of Adult GH Deficiency

A. Dobs, M. Molitch, R. Swerdloff, 2013, The Journal of clinical endocrinology and metabolism.

Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.

D. Dunger, C. Acerini, A. Umpleby, 2004, The Journal of clinical endocrinology and metabolism.

Factors that Affect the Dosing Regimen of Growth Hormone Replacement Therapy in Adults with Growth Hormone Deficiency

K. Yuen, 2007 .

Effects of Recombinant Human IGF-I/IGF-Binding Protein-3 Complex on Glucose and Glycerol Metabolism in Type 1 Diabetes

D. Dunger, C. Acerini, F. Shojaee-Moradie, 2006, Diabetes.

Sensitivity and specificity of the macimorelin test for diagnosis of AGHD.

P. Chanson, M. Korbonits, C. Strasburger, 2020, Endocrine connections.

Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.

D. Dunger, K. Yuen, 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Oral Octreotide: A Review of Recent Clinical Trials and Practical Recommendations for Its Use in the Treatment of Patients With Acromegaly.

K. Yuen, S. Samson, 2022, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: UPDATE ON GROWTH HORMONE STIMULATION TESTING AND PROPOSED REVISED CUT-POINT FOR THE GLUCAGON STIMULATION TEST IN THE DIAGNOSIS OF ADULT GROWTH HORMONE DEFICIENCY.

A. Hoffman, S. Samson, K. Yuen, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Multidisciplinary management of acromegaly: A consensus

P. Chanson, A. Mamelak, F. Casanueva, 2020, Reviews in Endocrine and Metabolic Disorders.

Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults

K. Yuen, D. Cook, B. Biller, 2013, Pituitary.

Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency?

M. Molitch, K. Yuen, D. Cook, 2009, The Journal of clinical endocrinology and metabolism.

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults

P. Chanson, S. Radovick, M. Dattani, 2018, Endocrine connections.

New causes of hypophysitis.

K. Yuen, V. Popović, P. Trainer, 2019, Best practice & research. Clinical endocrinology & metabolism.

Association of decreased sperm motility and increased seminal plasma IGF-I, IGF-II, IGFBP-2, and PSA levels in infertile men

A. Hoffman, K. Yuen, A. Bongso, 2021, Endocrine.

Decreased Sperm Motility is Associated with Increased Seminal Plasma IGF-I, IGF-II, IGFBP-2 and PSA Levels in Male Infertility

A. Hoffman, K. Yuen, A. Bongso, 2021 .

Sodium and water perturbations in patients who had an acute stroke: clinical relevance and management strategies for the neurologist

K. Yuen, Minhwan Kim, V. Sharf, 2021, Stroke and vascular neurology.

Evaluation of the Pituitary Function with Insulin Tolerance (Hypoglycaemia) Testing: Are There Any Differences Using Insulin Lispro Compared to Regular Insulin?

K. Yuen, D. Cook, R. Amin, 2008, Hormone Research in Paediatrics.

Pasireotide treatment does not modify hyperglycemic and corticosterone acute restraint stress responses in rats

M. Bizzi, K. Yuen, H. Schmid, 2018, Stress.

Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study

J. Schopohl, M. Roughton, K. Yuen, 2019, Pituitary.

Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas with Adjuvant Temozolomide Chemotherapy: A Review

M. Mayberg, K. Yuen, M. Moisi, 2016, Cureus.

Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.

M. Kołtowska-Häggström, M. Geffner, K. Yuen, 2013, European journal of endocrinology.

A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury

B. Masel, M. Jaffee, R. Urban, 2022, Growth Hormone & IGF Research.

Development of Human Pituitary Neuroendocrine Tumor Organoids to Facilitate Effective Targeted Treatments of Cushing’s Disease

J. Eschbacher, A. Little, J. Churko, 2022, Cells.

Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers

M. Christ-Crain, K. Yuen, A. Ribeiro-Oliveira, 2021, Pituitary.

Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations

S. Samson, K. Yuen, M. Gordon, 2020, Clinical Diabetes and Endocrinology.

OFF-LABEL USE AND MISUSE OF TESTOSTERONE, GROWTH HORMONE, THYROID HORMONE, AND ADRENAL SUPPLEMENTS: RISKS AND COSTS OF A GROWING PROBLEM.

J. Jonklaas, M. Fleseriu, C. Boguszewski, 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum IGF‐1 levels

H. Shahinian, K. Yuen, D. Cook, 2008, Clinical endocrinology.

Mifepristone Increases Thyroid Hormone Requirements in Patients With Central Hypothyroidism: A Multicenter Study

M. Fleseriu, K. Yuen, L. Nachtigall, 2019, Journal of the Endocrine Society.

Experience of a Pituitary Clinic for US Military Veterans With Traumatic Brain Injury.

Jose M Garcia, K. Yuen, Lindsey J. Anderson, 2021, Journal of the Endocrine Society.

Adult growth hormone deficiency: clinical advances and approaches to improve adherence

K. Yuen, B. Miller, S. Llahana, 2019, Expert review of endocrinology & metabolism.

Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency

K. Ho, G. Johannsson, K. Yuen, 2022, Pituitary.

Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH)

A. Peters, K. Yuen, H. East, 2019, The Journal of clinical endocrinology and metabolism.

Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency

D. Dunger, P. Murgatroyd, J. Frystyk, 2005 .

Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients

K. Yuen, B. Miller, 2022, Drug design, development and therapy.

Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.

M. Korbonits, A. Klibanski, G. Johannsson, 2014, The Journal of clinical endocrinology and metabolism.

Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study.

K. Yuen, G. Rayman, N. Baker, 2002, Diabetes care.

Applied physiology of glucose control

D. Dunger, K. Yuen, K. Beardsall, 2003 .

Long-Acting Growth Hormone Preparations - Current Status and Future Considerations.

K. Yuen, B. Miller, Eric Velazquez, 2019, The Journal of clinical endocrinology and metabolism.

A case series of atypical features of patients with biopsy-proven isolated IgG4-related hypophysitis and normal serum IgG4 levels

Brendan J. McCullough, M. Mayberg, K. Yuen, 2018, Pituitary.

EGFR/ErbB2 targeting lapatinib therapy for aggressive prolactinomas.

S. Melmed, M. Fleseriu, K. Yuen, 2020, The Journal of clinical endocrinology and metabolism.

Genetically Engineered Human Pituitary Corticotroph Tumor Organoids Exhibit Divergent Responses To Glucocorticoid Receptor Modulators

J. Eschbacher, A. Livolsi, A. Little, 2022, bioRxiv.

D. Dunger, P. Murgatroyd, J. Frystyk, 2005, Clinical endocrinology.

Short-term low-dose growth hormone administration in subjects with impaired glucose tolerance and the metabolic syndrome: effects on beta-cell function and post-load glucose tolerance.

D. Dunger, N. Wareham, J. Frystyk, 2004, European journal of endocrinology.

Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases

K. Yuen, D. Donegan, A. Chang, 2021, Clinical medicine insights. Endocrinology and diabetes.

Influence of glucocorticoids and growth hormone on insulin sensitivity in humans

M. Riddle, K. Yuen, L. E. Chong, 2013, Diabetic medicine : a journal of the British Diabetic Association.

Twenty‐four‐hour profiles of plasma glucose, insulin, C‐peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short‐term, medium‐dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin secretion and action

M. Riddle, K. Yuen, P. McDaniel, 2012, Clinical Endocrinology.

Growth hormone deficiency, acromegaly and COVID-19: Transitioning from media reports to knowledge and a growth hormone hypothesis

K. Yuen, 2020, Growth Hormone & IGF Research.

Pituitary gland recovery following fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenoma: results of a prospective multicenter study.

J. Fernandez-Miranda, P. Gardner, M. Chicoine, 2019, Journal of neurosurgery.

Rethinking the management of immune checkpoint inhibitor‐related adrenal insufficiency in cancer patients during the COVID‐19 pandemic

A. Azadi, K. Yuen, J. Findling, 2021, Endocrinology, diabetes & metabolism.

Sodium Perturbations After Pituitary Surgery.

A. Little, K. Yuen, Adnan Ajmal, 2019, Neurosurgery clinics of North America.

Adrenal insufficiency in pregnancy: challenging issues in diagnosis and management

K. Yuen, C. Koch, L. E. Chong, 2013, Endocrine.

Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic–pituitary–adrenal axes in adults: results from a prospective randomized multicenter study

J. Bena, K. Yuen, B. Biller, 2016, Pituitary.

Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency.

P. Sluss, M. Bredella, K. Yuen, 2014, The Journal of clinical endocrinology and metabolism.

Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study.

K. Guskiewicz, M. Sim, Christina Wang, 2014, Journal of neurotrauma.

A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient Adults

T. Bailey, G. Conway, K. Yuen, 2013, The Journal of clinical endocrinology and metabolism.

Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors.

R. Murray, L. Cohen, G. Armstrong, 2021, Endocrine reviews.

Is lack of recombinant GH-releasing hormone in the United States a setback or time to consider glucagon testing for adult growth hormone deficiency?

M. Molitch, K. Yuen, D. Cook, 2009 .

Laboratory Diagnosis of Growth Hormone Deficiency in Adults

K. Yuen, 2016 .

Growth Hormone Deficiency Following Traumatic Brain Injury in Pediatric and Adolescent Patients: Presentation, Treatment, and Challenges of Transitioning from Pediatric to Adult Services

J. Cárdenas, P. Backeljauw, K. Yuen, 2023, Journal of neurotrauma.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: A NEUROENDOCRINE APPROACH TO PATIENTS WITH TRAUMATIC BRAIN INJURY.

K. Yuen, N. Tritos, D. Kelly, 2015, Endocrine Practice.

Adult growth hormone deficiency: Optimizing transition of care from pediatric to adult services.

C. Alter, S. Samson, K. Yuen, 2020, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update: executive summary of recommendations.

M. Vance, K. Yuen, D. Cook, 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers

J. Eschbacher, J. Almeida, G. Zadeh, 2019, Pituitary.

Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels?

R. Bennett, K. Yuen, D. Cook, 2007, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Changes in Quality of Life After Long-Term Biochemical Control of Acromegaly

W. Woodmansee, K. Yuen, L. Nachtigall, 2021, Pituitary.

Health Benefit Costs and Absenteeism Among Employed Patients With Acromegaly.

K. Yuen, A. Ribeiro-Oliveira, R. Brook, 2021, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of care

K. Yuen, A. Ribeiro-Oliveira, N. Kleinman, 2021, Journal of medical economics.

Evolution of postoperative pituitary adenoma resection cavities assessed by magnetic resonance imaging and implications regarding radiotherapy timing and modality

A. Little, K. Yuen, W. White, 2021, Clinical Imaging.

Early postoperative MRI and detection of residual adenoma after transsphenoidal pituitary surgery.

A. Little, K. Yuen, W. White, 2020, Journal of neurosurgery.

Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®

K. Yuen, R. Amin, 2011, Patient preference and adherence.

Effects of growth hormone receptor antagonism and somatostatin analog administration on quality of life in acromegaly

W. Woodmansee, K. Yuen, L. Nachtigall, 2020, Clinical endocrinology.

Long-term efficacy and safety of pegvisomant therapy in acromegaly.

K. Yuen, L. Katznelson, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Management of Acromegaly With Pasireotide LAR: A Case Study of Sustained Biochemical Control and Tumor Volume Reduction Without Worsening of Glycemia

K. Yuen, 2016 .

Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients

M. Korbonits, A. V. van Beek, P. Touraine, 2022, The Journal of clinical endocrinology and metabolism.

Hearing impairment and depressive symptoms in an older chinese population.

C. Vanhasselt, K. Yuen, Michael C F Tong, 2010, Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale.

Cardiogenic Shock Due to Non-Ischemic Cardiomyopathy Induced by Severe Anterior Hypopituitarism.

K. Yuen, J. Gelow, J. Mudd, 2015, AACE clinical case reports.

Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician

K. Yuen, A. Heaney, V. Popović, 2016, Endocrine.

Validation of the Paediatric Hearing Impairment Caregiver Experience (PHICE) Questionnaire.

K. Yuen, L. Xiang, L. Lim, 2014, Annals of the Academy of Medicine, Singapore.

Evaluation of FKBP5 as a cortisol activity biomarker in patients with ACTH-dependent Cushing syndrome

L. Chandramohan, B. Hatipoglu, K. Yuen, 2021, Journal of clinical & translational endocrinology.

Adult growth hormone deficiency guidelines: more difficult than it seems to incorporate into clinical practice universally.

K. Yuen, 2021, European journal of endocrinology.

Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement

M. Geffner, K. Yuen, E. Erfurth, 2018, The Journal of clinical endocrinology and metabolism.

Short‐term suppression of elevated growth hormone concentrations following insulin‐like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates

D. Dunger, K. Yuen, R. Dalton, 2006, Clinical endocrinology.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY (AACE) DISEASE STATE CLINICAL REVIEW EVALUATION AND MANAGEMENT OF IMMUNE CHECKPOINT INHIBITOR-MEDIATED ENDOCRINOPATHIES: A PRACTICAL CASE-BASED CLINICAL APPROACH.

A. Gosmanov, L. Fecher, K. Yuen, 2022, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Treatment of Cushing's Disease with Pituitary-Targeting Seliciclib.

A. Mamelak, S. Melmed, M. Tighiouart, 2022, The Journal of clinical endocrinology and metabolism.

Family caregivers' perceptions and experiences of delirium in patients with advanced cancer

S. Nikoletti, K. Yuen, J. Greaves, 2008 .

Reevaluating goals of insulin therapy: perspectives from large clinical trials.

M. Riddle, K. Yuen, 2012, Endocrinology and metabolism clinics of North America.

Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis

A. Rogol, I. Bergadá, K. Ho, 2023, Endocrine connections.

EFFECTIVE MEDICAL THERAPY FOR CUSHING DISEASE CAN INCREASE THE SUSCEPTIBILITY TO RELATIVE HYPOCORTISOLISM

K. Yuen, F. Broyles, Jennifer U. Mercado, 2018 .

Corrigendum: Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogues

C. Boguszewski, K. Yuen, A. Hoffman, 2021, Frontiers in Endocrinology.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification

L. Esserman, A. Borowsky, L. Nieman, 2023, Nature Reviews Endocrinology.

GENETICALLY ENGINEERED HUMAN PITUITARY CORTICOTROPH TUMOR ORGANOIDS EXHIBIT DIVERGENT RESPONSES TO GLUCOCORTICOID RECEPTOR MODULATORS.

J. Eschbacher, A. Livolsi, A. Little, 2023, Translational research : the journal of laboratory and clinical medicine.

Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study

J. Schopohl, M. Roughton, K. Yuen, 2019, Pituitary.

Primary treatment regimen and diabetes insipidus as predictors of health outcomes in adults with childhood-onset craniopharyngioma.

M. Geffner, K. Yuen, D. Cook, 2014, The Journal of clinical endocrinology and metabolism.

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.

M. Vance, K. Yuen, D. Cook, 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Clinical characteristics and effects of GH replacement in adults with childhood

M. Geffner, K. Yuen, D. Cook, 2013 .